Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor and Apixaban with or without ASA in healthy males
NCT02080858Phase 1Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind trial of ticagrelor and apixaban in Atrial fibrillation (AFib) and acute coronary syndrome (ACS), sponsored by Medical University of Vienna. Started May 2014; status: completed.
02
Drugs
ticagrelorapixaban
03
Conditions
Atrial fibrillation (AFib)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02080858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080858.